Literature DB >> 15755470

Gender differences in hypertension and kidney disease.

Daisy Reyes1, Susie Q Lew, Paul L Kimmel.   

Abstract

Gender differences exist in hypertension, the prevalence of several renal diseases, progression of established renal disease, and within the ESRD program, including renal transplantation. Sex hormones play key roles in the pathogenesis and outcome of disease processes. Observational data suggest gender differences in the prevalence and outcome of several renal diseases. The molecular mechanisms associated with physiologic phenomena needed to explain gender differences in renal disorders, however, remain largely obscure. The interaction of psychosocial, economic, medical, and genetic differences associated with discrepancies between the genders in the process of receiving a renal transplant and sustaining graft function are currently unclear. Additional studies are needed in these and other areas to explain gender differences in the incidence, prevalence, and outcome of renal disease.

Entities:  

Mesh:

Year:  2005        PMID: 15755470     DOI: 10.1016/j.mcna.2004.11.010

Source DB:  PubMed          Journal:  Med Clin North Am        ISSN: 0025-7125            Impact factor:   5.456


  16 in total

1.  Cisplatin nephrotoxicity as a model of chronic kidney disease.

Authors:  Mingjun Shi; Kathryn L McMillan; Junxia Wu; Nancy Gillings; Brianna Flores; Orson W Moe; Ming Chang Hu
Journal:  Lab Invest       Date:  2018-06-01       Impact factor: 5.662

2.  Sex differences in gout epidemiology: evaluation and treatment.

Authors:  L R Harrold; R A Yood; T R Mikuls; S E Andrade; J Davis; J Fuller; K A Chan; D Roblin; M A Raebel; A Von Worley; R Platt; K G Saag
Journal:  Ann Rheum Dis       Date:  2006-04-27       Impact factor: 19.103

3.  The Combined Influence of Psychological Factors on Biomarkers of Renal Functioning in African Americans.

Authors:  Georica K Gholson; Denée T Mwendwa; Regina Sims Wright; Clive O Callender; Alfonso L Campbell
Journal:  Ethn Dis       Date:  2015       Impact factor: 1.847

Review 4.  Gender Mainstreaming and Transplant Surgery.

Authors:  Eva Maria Teegen; Isabell Krebs; Corinna Langelotz; Johann Pratschke; Beate Rau
Journal:  Visc Med       Date:  2016-07-29

5.  Effects of moderate global maternal nutrient reduction on fetal baboon renal mitochondrial gene expression at 0.9 gestation.

Authors:  Susana P Pereira; Paulo J Oliveira; Ludgero C Tavares; António J Moreno; Laura A Cox; Peter W Nathanielsz; Mark J Nijland
Journal:  Am J Physiol Renal Physiol       Date:  2015-03-11

6.  Sex, weight status, and chronic kidney disease among African Americans: the Jackson Heart Study.

Authors:  Marino A Bruce; Bettina M Beech; Errol D Crook; Mario Sims; Derek M Griffith; Sean L Simpson; Jamy Ard; Keith C Norris
Journal:  J Investig Med       Date:  2013-04       Impact factor: 2.895

7.  Race and sex differences in hypertension control in CKD: results from the Kidney Early Evaluation Program (KEEP).

Authors:  Obidiugwu Kenrik Duru; Suying Li; Claudine Jurkovitz; George Bakris; Wendy Brown; Shu-Cheng Chen; Allan Collins; Michael Klag; Peter A McCullough; Janet McGill; Andrew Narva; Pablo Pergola; Ajay Singh; Keith Norris
Journal:  Am J Kidney Dis       Date:  2008-02       Impact factor: 8.860

Review 8.  Sex/gender medicine. The biological basis for personalized care in cardiovascular medicine.

Authors:  Faisal A Arain; Fatima H Kuniyoshi; Ahmed D Abdalrhim; Virginia M Miller
Journal:  Circ J       Date:  2009-09-04       Impact factor: 2.993

9.  Effects of flaxseed derivatives in experimental polycystic kidney disease vary with animal gender.

Authors:  Malcolm R Ogborn; Evan Nitschmann; Neda Bankovic-Calic; Hope A Weiler; Harold M Aukema
Journal:  Lipids       Date:  2006-12       Impact factor: 1.646

10.  Relationship between prehypertension and chronic kidney disease in middle-aged people in Korea: the Korean genome and epidemiology study.

Authors:  Min-Ju Kim; Nam-Kyoo Lim; Hyun-Young Park
Journal:  BMC Public Health       Date:  2012-11-09       Impact factor: 3.295

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.